Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Rumors

Rumors

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Equities
  • General
  • M&A
  • Markets
  • Media
  • News
  • Rumors

Citigroup Eyes New Private Credit Strategy Next Year: Report

By Vandana Singh
November 22, 10:15 AM
Citigroup Inc (NYSE: C) is reportedly poised to venture into direct lending, aiming to debut this new strategy by early January, reflecting a broader trend among banks seeking to tap into the burgeoning $1.6 trillion private credit market.

BCS

Read More
2 minute read
  • Fintech
  • General
  • Management
  • Markets
  • News
  • Rumors
  • Tech
  • Top Stories

Sam Altman In Discussions About OpenAI Return As Employees Revolt And MSFT Picks Up The Pieces

By Neil Dennis
November 21, 3:49 PM
There were threats from the OpenAI staff of mass resignations if Sam Altman was not reinstated.

MSFT

Read More
1 minute read
  • Equities
  • General
  • Health Care
  • M&A
  • Markets
  • Media
  • Movers
  • News
  • Rumors

Diagnostics Firm QuidelOrtho Contemplates Selling Transfusion Medicine Arm Valued Up To $2B: Report

By Vandana Singh
November 16, 11:16 AM
QuidelOrtho Corp (NASDAQ: QDEL) is reportedly contemplating the potential sale of its transfusion medicine arm.

QDEL

Read More
1 minute read
  • Equities
  • General
  • Health Care
  • M&A
  • Markets
  • Media
  • News
  • Rumors

Major Buyout Firms Eye Sanofi’s Consumer Health Division Spinoff Valued Over $20B

By Vandana Singh
November 16, 7:58 AM
Sanofi SA (NYSE: SNY) has reportedly initiated talks with Rothschild & Co. to explore the possibility of spinning off its consumer health division, which could potentially value the business at over $20 billion. 

GSK

Read More
2 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • M&A
  • News
  • Rumors

Novo Nordisk Seeks Obesity, Diabetes ‘Bolt-On’ Deals As It Beefs Up Capacity To Meet Soaring Demand

By Vandana Singh
November 10, 9:34 AM
Novo Nordisk A/S (NYSE: NVO) plans to invest more than DKK 42 billion

NVO

Read More
2 minute read
  • General
  • Health Care
  • Large Cap
  • M&A
  • Movers
  • News
  • Rumors

Healthcare Insurance Giant Cigna Mulls Offloading Medicare Advantage Business

By Vandana Singh
November 6, 2:17 PM
Cigna Corporation (NYSE: CI) is reportedly contemplating the sale of its Medicare Advantage business and working with an investment bank to explore options for a business that could be worth billio

CI

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Media
  • News
  • Rumors
  • Tech

Apple’s New Global Play: iPhone 17 Production To Start In India, Not China, Says Top Analyst

By Shomik Sen Bhattacharjee
November 2, 2:12 AM
This story was first published on the Benzinga India portal.

AAPL

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • M&A
  • News
  • Rumors

Potential Takeover In Works for Cardiovascular Treatment Focused Cytokinetics

By Vandana Singh
November 1, 1:38 PM
Cytokinetics Inc (NASDAQ: CYTK), a late-stage biotech company focused on cardiovascular treatments, is reportedly exploring potential takeover options as it has garnered interest from at least one major pharmaceutical company in recent months.

CYTK

Read More
1 minute read
  • Commodities
  • General
  • M&A
  • Markets
  • News
  • Rumors

TC Energy Explores Asset Sales Worth $10B, Debt Reduction on the Horizon

By Vandana Singh
October 30, 9:27 AM
Pipeline and transportation company TC Energy Corp (NYSE: TRP) is reportedly exploring selling a minority stake in ANR Pipeline Co for an estimated enterprise value of around $3 billion. 

TRP

Read More
4 minute read
  • Cannabis
  • Contracts
  • Financing
  • Global
  • Legal
  • Management
  • Markets
  • News
  • Penny Stocks
  • Psychedelics
  • Rumors
  • Small Cap

Psyched: Cybin’s Center Stage In Novel Psychedelics, Musk & Ramaswamy, Britney’s Memoirs And More

By Lara Goldstein
October 29, 10:48 PM
Cybin Officially Owns Small Pharma, Gets Three New International Patents Granted

ATAI

Posts navigation

1 2 … 38 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service